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underwent the 70 staged procedures. Furthermore, Hertzer
found that the diameter of unresected aneurysms documented by
noninvasive means significantly influenced the risk for rupture.
The cumulative incidence of rupture was 20% for patients with
aneurysms less than 6 cm compared with 69% for those greater
than 6 cm (P = .0048).
In the study by Acinapura,2 20 patients with severe coronary
disease underwent myocardial revascularizations followed by
staged abdominal aortic aneurysmectomy 7 to 12 days following.
Two of these patients required emergency aortic replacement on
the seventh and eighth day postoperatively because of sponta-
neous rupture.
We realize that this is a controversial area and not all surgeons
would agree with the viewpoint expressed within our study. Our
primary goals in staging these patients within the same hospital-
ization were to limit the mortality and morbidity associated with
combined procedures and to attempt to reduce the risk of post-
operative aneurysm rupture in patients with severe coronary dis-
ease by performing aortic replacement with a short interprocedure
interval within the same hospital stay. Ideally, a controlled prospec-
tive randomized trial would be best to sort out this controversy as
was alluded to in the paper.
Philip S. K. Paty, MD, (Senior Author)
Institute for Vascular Health and Disease
Albany Medical College
Albany, NY
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The UK small aneurysm trial
To the Editors:
The UK Small Aneurysm Trial showed no survival benefit of
early surgery compared with surveillance and possible subsequent
repair of 4.0- to 5.5-cm diameter AAAs. Using data from this
trial, we found that early surgery was, in fact, cost-effective when
compared with surveillance if calculated over the entire life
expectancy of the population (J Vasc Surg 2000;31:217-26). This
was due to a small difference in mortality rates between the two
groups (7.0% per year for early surgery vs 7.4% per year for sur-
veillance), which became significant when projected over the
patients’ entire lifetime, rather than the 6-year follow-up of the
UK Trial. Our analysis was intended to show that a small differ-
ence in mortality rate can have a substantial impact on decision
analysis, even though the clinical trial could not be powered to
statistically validate this difference. However, since the mortality
rates were not statistically significant between groups in the UK
trial, Dr K. Craig Kent, in his thoughtful discussion of our paper,
asked us to model the scenario of equal mortality rates between
the groups. We have subsequently done this and, in this letter,
report the impact of this different assumption on our cost-effec-
tiveness calculation.
We used the same model described previously, taking data
directly from the published UK Trial.1,2 However, rather than
using the observed annual mortality rates (7.0% for early surgery
and 7.4% for surveillance), we used an annual mortality of 7.0% for
both groups. We again subtracted operative mortality from both
the early surgery and surveillance groups. As before, we used oper-
ative mortality rates taken from the UK trial (5.8% for early surgery
and 7.2% for surveillance) for the base case analysis. With sensitiv-
ity analysis, operative mortality was again varied across a plausible
range (0%-10%); the same relative change in operative mortality was
applied to both groups. Our analysis shows that with equal annual
mortality rates, in the base case analysis, with an operative mortal-
ity of 5.8%, early surgery is not cost-effective (marginal cost-effec-
tiveness ratio $90,400 per quality-adjusted life year [QALY]).
However, as shown in the Figure, lower operative mortality renders
early surgery cost-effective, with marginal cost-effectiveness ratios
below $20,000 per QALY at operative mortality rates below 4%.
Such rates are achievable in selected patients. Among US Medicare
patients undergoing elective AAA repair in 1995, the 30-day mor-
tality rate was 3.0% for ages 65 to 69, and 4.0% for ages 70 to 74. 
Thus, even assuming equal long-term mortality rate, our
analysis again demonstrates that early surgery for small abdominal
aortic aneurysms can be cost-effective, if low operative mortality
can be achieved.
We would like to thank Dr Kent for prompting this analysis.
Marc L. Schermerhorn, MD
Jack L. Cronenwett, MD
Dartmouth-Hitchcock Medical Center
Lebanon, NH
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Marginal cost-effectiveness ratio of early surgery compared with
surveillance as a function of operative mortality rate, with data
from UK Small Aneurysm Trial. The dashed line indicates opera-
tive mortality (5.8%) observed in UK Trial, at which early surgery
is not cost-effective, assuming equal late mortality rates between
the groups (see text). However, at operative mortality of 4% or
less, early surgery is clearly cost-effective with this model.
